A real-world study evaluating of existing treatments for patients with chronic urticaria

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900027070

Enrollment

Unknown

Registered

2019-10-30

Start date

2019-10-30

Completion date

Unknown

Last updated

2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic urticaria

Interventions

Case Series:According to the need

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The age of 18 years of age or older, men and women not limited; 2. The clinical symptoms and signs in accordance with the diagnosis of chronic urticaria, diagnostic criteria for all (meet) : a sexual urticaria, skin appear;Itch as the main symptoms.A course of 6 or more weeks;The cause is not clear;At least 2 times a week or two days of symptom onset, duration of a single wind group 24 hours or less; Merger or not angioedema. 3.outpatients

Exclusion criteria

Exclusion criteria: 1. Patients taking antihistamine drugs, do not receive treatment during the drug withdrawal; 2. Physical urticaria, genetic vascular edema and other clear causes (such as drugs, infection, etc.) caused by urticaria; 3. Patients with hematologic tumor, autoimmune disease, upper respiratory tract infection, being treated with anticoagulant drugs and systemic glucocorticoid therapy; 4. Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
weekly urticaria activity score;	—

Countries

China

Contacts

Public ContactLi Linfeng

Department of Dermatology, Beijing Friendship Hospital, Capital Medical University

zoonli@sina.com+86 13693620186

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026